Gina Massa Mias
Compliance Officer bij ESBATech, a Novartis Co. GmbH
Actieve functies van Gina Massa Mias
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ESBATech, a Novartis Co. GmbH
ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Compliance Officer | - | - |
Corporate Officer/Principal | - | - |
Loopbaan van Gina Massa Mias
Eerdere bekende functies van Gina Massa Mias
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
NOVARTIS AG | Corporate Officer/Principal | 01-01-2005 | - |
Opleiding van Gina Massa Mias
University of Massachusetts | Masters Business Admin |
Statistieken
Internationaal
Zwitserland | 3 |
Verenigde Staten | 2 |
Operationeel
Corporate Officer/Principal | 2 |
Compliance Officer | 1 |
Masters Business Admin | 1 |
Sectoraal
Commercial Services | 2 |
Consumer Services | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
NOVARTIS AG | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
ESBATech, a Novartis Co. GmbH
ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Commercial Services |
- Beurs
- Insiders
- Gina Massa Mias
- Ervaring